spirodecanone has been researched along with pentobarbital in 1 studies
*Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) [MeSH]
*Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, T; Fujiwara, T; Kanai, Y; Kato, H; Kogure, K; Murakami, F | 1 |
1 other study(ies) available for spirodecanone and pentobarbital
| Article | Year |
|---|---|
Effects of vinconate and pentobarbital against postischemic alterations in spirodecanone binding sites in the gerbil brain.
Topics: Animals; Autoradiography; Binding Sites; Corpus Striatum; Gerbillinae; Glial Fibrillary Acidic Protein; Hippocampus; Ischemic Attack, Transient; Male; Pentobarbital; Receptors, Dopamine; Spiro Compounds; Vinca Alkaloids | 1994 |